414 related articles for article (PubMed ID: 23937413)
41. Involvement of LTD(4)in allergic pulmonary inflammation in mice: modulation by cysLT(1)antagonist MK-571.
Blain JF; Sirois P
Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):361-8. PubMed ID: 10913229
[TBL] [Abstract][Full Text] [Related]
42. A geranyl acetophenone targeting cysteinyl leukotriene synthesis prevents allergic airway inflammation in ovalbumin-sensitized mice.
Ismail N; Jambari NN; Zareen S; Akhtar MN; Shaari K; Zamri-Saad M; Tham CL; Sulaiman MR; Lajis NH; Israf DA
Toxicol Appl Pharmacol; 2012 Mar; 259(2):257-62. PubMed ID: 22266348
[TBL] [Abstract][Full Text] [Related]
43. Pathophysiological role of mast cells in collagen-induced arthritis: study with a cysteinyl leukotriene receptor antagonist, montelukast.
Shiota N; Shimoura K; Okunishi H
Eur J Pharmacol; 2006 Oct; 548(1-3):158-66. PubMed ID: 16949072
[TBL] [Abstract][Full Text] [Related]
44. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
[TBL] [Abstract][Full Text] [Related]
45. IL-23 Is Essential for the Development of Elastase-Induced Pulmonary Inflammation and Emphysema.
Fujii U; Miyahara N; Taniguchi A; Waseda K; Morichika D; Kurimoto E; Koga H; Kataoka M; Gelfand EW; Cua DJ; Yoshimura A; Tanimoto M; Kanehiro A
Am J Respir Cell Mol Biol; 2016 Nov; 55(5):697-707. PubMed ID: 27351934
[TBL] [Abstract][Full Text] [Related]
46. Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation.
Nadeem A; Obiefuna PC; Wilson CN; Mustafa SJ
Eur J Pharmacol; 2006 Dec; 551(1-3):116-24. PubMed ID: 17027749
[TBL] [Abstract][Full Text] [Related]
47. Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.
Zovko A; Yektaei-Karin E; Salamon D; Nilsson A; Wallvik J; Stenke L
Oncol Rep; 2018 Aug; 40(2):902-908. PubMed ID: 29845257
[TBL] [Abstract][Full Text] [Related]
48. Montelukast versus Dexamethasone Treatment in a Guinea Pig Model of Chronic Pulmonary Neutrophilic Inflammation.
Abdel Kawy HS
COPD; 2016 Aug; 13(4):455-63. PubMed ID: 26751767
[TBL] [Abstract][Full Text] [Related]
49. Effect of inhaled KP-496, a novel dual antagonist of the cysteinyl leukotriene and thromboxane A2 receptors, on a bleomycin-induced pulmonary fibrosis model in mice.
Kurokawa S; Suda M; Okuda T; Miyake Y; Matsumura Y; Ishimura M; Saito R; Nakamura T
Pulm Pharmacol Ther; 2010 Oct; 23(5):425-31. PubMed ID: 20457270
[TBL] [Abstract][Full Text] [Related]
50. Leukotrienes produced in allergic lung inflammation activate alveolar macrophages.
Silva RC; Landgraf MA; Hiyane MI; Pacheco-Silva A; Câmara NO; Landgraf RG
Cell Physiol Biochem; 2010; 26(3):319-26. PubMed ID: 20798516
[TBL] [Abstract][Full Text] [Related]
51. Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma.
Wu AY; Chik SC; Chan AW; Li Z; Tsang KW; Li W
Clin Exp Allergy; 2003 Mar; 33(3):359-66. PubMed ID: 12614451
[TBL] [Abstract][Full Text] [Related]
52. Mast cell mediators cause early allergic bronchoconstriction in guinea-pigs in vivo: a model of relevance to asthma.
Riley JP; Fuchs B; Sjöberg L; Nilsson GP; Karlsson L; Dahlén SE; Rao NL; Adner M
Clin Sci (Lond); 2013 Dec; 125(11):533-42. PubMed ID: 23799245
[TBL] [Abstract][Full Text] [Related]
53. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
Said MM; Bosland MC
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
[TBL] [Abstract][Full Text] [Related]
54. Mepacrine alleviates airway hyperresponsiveness and airway inflammation in a mouse model of asthma.
Ram A; Mabalirajan U; Singh SK; Singh VP; Ghosh B
Int Immunopharmacol; 2008 Jun; 8(6):893-9. PubMed ID: 18442795
[TBL] [Abstract][Full Text] [Related]
55. Montelukast prevents the decrease of interleukin-10 and inhibits NF-kappaB activation in inflammatory airway of asthmatic guinea pigs.
Wu Y; Zhou C; Tao J; Li S
Can J Physiol Pharmacol; 2006 May; 84(5):531-7. PubMed ID: 16902598
[TBL] [Abstract][Full Text] [Related]
56. Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in vitro model of asthma.
Rovati GE; Baroffio M; Citro S; Brichetto L; Ravasi S; Milanese M; Crimi E; Brusasco V
Respir Res; 2006 Jul; 7(1):103. PubMed ID: 16875498
[TBL] [Abstract][Full Text] [Related]
57. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
Langlois A; Ferland C; Tremblay GM; Laviolette M
J Allergy Clin Immunol; 2006 Jul; 118(1):113-9. PubMed ID: 16815146
[TBL] [Abstract][Full Text] [Related]
58. Increased oxidative stress in the airway and development of allergic inflammation in a mouse model of asthma.
Park CS; Kim TB; Lee KY; Moon KA; Bae YJ; Jang MK; Cho YS; Moon HB
Ann Allergy Asthma Immunol; 2009 Sep; 103(3):238-47. PubMed ID: 19788022
[TBL] [Abstract][Full Text] [Related]
59. Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier.
Zhou L; Sun X; Shi Y; Liu J; Luan G; Yang Y
Inflammopharmacology; 2019 Oct; 27(5):933-940. PubMed ID: 31313075
[TBL] [Abstract][Full Text] [Related]
60. Loss of IL-33 enhances elastase-induced and cigarette smoke extract-induced emphysema in mice.
Morichika D; Taniguchi A; Oda N; Fujii U; Senoo S; Itano J; Kanehiro A; Kitaguchi Y; Yasuo M; Hanaoka M; Satoh T; Akira S; Kiura K; Maeda Y; Miyahara N
Respir Res; 2021 May; 22(1):150. PubMed ID: 33992109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
